Announcements - Search results

Search results: Company announcements for
ONCOSIL MEDICAL LTD (OSL)
Released between 01/01/2018 and 31/12/2018

Didn't find the announcement you were after? Search again.

Announcements released as OSL
Date Price sens. Headline
11/12/2018
12:30 PM
  Initial Director's Interest Notice
2 pages 218.2KB
10/12/2018
9:43 AM
  Director Appointment/Resignation
2 pages 667.4KB
02/11/2018
9:49 AM
  Loan Share Vesting Conditions Met
2 pages 642.0KB
31/10/2018
9:56 AM
  Appendix 3B
12 pages 697.9KB
30/10/2018
5:27 PM
  Results of Annual General Meeting 2018 - Amended
1 page 644.0KB
30/10/2018
2:09 PM
  Results of Annual General Meeting 2018
1 page 644.2KB
30/10/2018
9:33 AM
  2018 AGM CEO Presentation
27 pages 2.2MB
29/10/2018
8:38 AM
asterix Appendix 4C - quarterly
10 pages 1.1MB
25/10/2018
9:20 AM
asterix PanCo Study Interim Analysis
4 pages 844.9KB
28/09/2018
8:39 AM
  2018 Notice of General Meeting & Proxy Form
22 pages 436.7KB
28/09/2018
8:38 AM
  2018 Annual Report
60 pages 1.7MB
28/09/2018
8:31 AM
  2018 Appendix 4G and Corporate Governance Statement
17 pages 590.8KB
24/09/2018
10:02 AM
asterix R&D Refund - 2018 Financial Year
2 pages 650.1KB
30/08/2018
8:44 AM
asterix IQVIA appointed EU Market Access and Reimbursement Advisor
3 pages 739.1KB
22/08/2018
4:11 PM
asterix Preliminary Final Report
50 pages 1.9MB
26/07/2018
9:07 AM
  Oncosil Company Update Presentation
24 pages 2.2MB
25/07/2018
9:47 AM
asterix Appendix 4C & Quarterly Update
8 pages 1.1MB
05/07/2018
9:59 AM
  OSL to present at Monsoon Communications Investor Event
26 pages 2.7MB
04/06/2018
9:23 AM
  OncoSil Company Update Presentation
24 pages 2.1MB
31/05/2018
3:26 PM
asterix Response to Price Query
5 pages 1.0MB
18/05/2018
9:50 AM
  Appendix 3Y - Dr Roger Aston
2 pages 252.4KB
18/05/2018
9:49 AM
  Appendix 3Y - Dr Chris Roberts
2 pages 253.1KB
18/05/2018
9:48 AM
  Appendix 3Y - Dr Martin Cross
2 pages 252.4KB
17/05/2018
3:34 PM
  Appendix 3B
12 pages 706.4KB
14/05/2018
12:40 PM
  Results of Extraordinary General Meeting 2018
1 page 565.6KB
14/05/2018
9:02 AM
asterix Oncosil submits Clinical Study Report to Notified Body
2 pages 671.2KB
02/05/2018
9:09 AM
  OSL to present at Finance News Network Investor Session
26 pages 2.5MB
26/04/2018
4:17 PM
  Appendix 3Y - Dr Martin Cross Share Purchase Plan
2 pages 250.3KB
26/04/2018
4:16 PM
  Appendix 3Y - Daniel Kenny Share Purchase Plan
2 pages 251.6KB
26/04/2018
4:14 PM
  Appendix 3Y - Dr Chris Roberts Share Purchase Plan
2 pages 251.3KB
26/04/2018
10:15 AM
asterix Appendix 4C & Quarterly Update
9 pages 1.0MB
20/04/2018
12:18 PM
  Appendix 3B - Share Purchase Plan
12 pages 703.8KB
20/04/2018
8:41 AM
  ASIC Form 484
6 pages 528.3KB
19/04/2018
10:06 AM
  OncoSil Medical raises $4.0m from Share Purchase Plan
2 pages 504.5KB
13/04/2018
12:26 PM
  EGM Notice of Meeting & Proxy Form
18 pages 938.8KB
11/04/2018
4:09 PM
  Oncosil Medical Share Purchase Plan Closing Date Reminder
2 pages 501.6KB
09/04/2018
9:02 AM
  Oncosil Medical presents at Proactive Investors CEO Sessions
22 pages 2.2MB
04/04/2018
9:45 AM
asterix Clinical Programme Update
4 pages 746.0KB
03/04/2018
5:12 PM
  Change in substantial holding
3 pages 253.6KB
03/04/2018
1:55 PM
  CEO Interview - Clinical data update and outlook video
2 pages 498.2KB
28/03/2018
12:20 PM
  Ceasing to be a substantial holder for OSL
2 pages 84.7KB
28/03/2018
9:56 AM
asterix Oncosil Medical Share Purchase Plan
26 pages 1.3MB
28/03/2018
9:29 AM
  Cleansing Statement & Appendix 3B
14 pages 1.2MB
22/03/2018
12:10 PM
asterix Successful Completion of Capital Raising
3 pages 537.3KB
21/03/2018
9:44 AM
asterix Presentation-Surgical Resection Outcomes and Capital Raising
40 pages 3.4MB
21/03/2018
9:39 AM
asterix Surgical Resection Outcomes and Capital Raising
3 pages 546.7KB
21/03/2018
9:20 AM
asterix Trading Halt
2 pages 675.4KB
08/03/2018
9:18 AM
  OncoSil Company Update Presentation
23 pages 2.5MB
02/03/2018
3:53 PM
  Appendix 3B
12 pages 696.5KB
28/02/2018
9:20 AM
asterix Positive Early Study Results Continue
3 pages 854.7KB
21/02/2018
11:59 AM
asterix Appendix 4D & Half Yearly Report and Accounts
21 pages 1.1MB
08/02/2018
5:23 PM
  Change in substantial holding
3 pages 173.5KB
08/02/2018
9:40 AM
asterix First Subject Recruited in the United States
2 pages 658.7KB
08/02/2018
9:29 AM
asterix Response to ASX Appendix 4C Query
5 pages 917.6KB
30/01/2018
1:16 PM
  Change of Director's Interest Notice - Appendix 3Y
2 pages 251.9KB
30/01/2018
1:15 PM
  Change of Director's Interest Notice - Appendix 3Y
2 pages 251.1KB
30/01/2018
9:04 AM
  Final share buy-back notice - Appendix 3F
2 pages 424.1KB
29/01/2018
9:34 AM
asterix Appendix 4C & Quarterly Update
9 pages 1.0MB
16/01/2018
4:40 PM
asterix Additional Receipt of $0.6m R&D Tax Incentive Refund
2 pages 533.9KB
11/01/2018
9:24 AM
asterix Appendix 3C - Employee Loan Share Buy Back
5 pages 194.0KB
10/01/2018
9:35 AM
  20th Patient implanted with OncoSil device
2 pages 684.5KB

Useful Information

Previous codes used by this company

  • NDL changed to OSL

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.